Garry Watts succeeds John Brown as BTG chair
This article was originally published in Scrip
Specialist healthcare company BTG has elected Garry Watts to succeed Dr John Brown as non-executive chair effective from 1 January 2012. Mr Watts is chair of the Spire Healthcare group of private hospitals, senior director at Stagecoach Group and a non-executive director of Coca-Cola Enterprises. He was CEO of SSL International for seven years until its sale in November 2010 to Reckitt Benckiser.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.